ArticleJournal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing2026
Nurse Practitioner Opioid Prescribing Authority: A Comparative Policy Analysis of New Zealand, United States, and Australia.
Article in Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo examine nurse practitioner opioid prescribing authority across three countries, analyzing safety outcomes, workforce distribution patterns, access equity, and service to vulnerable populations using integrated nursing policy and patient-centered access frameworks.
designComparative policy analysis employing Russell and Fawcett's nursing policy framework overlaid on Levesque's access framework.
methodsWe analyzed regulatory documents, national prescribing databases, and published literature from New Zealand, United States, and Australia. Systematic searches identified 14 studies meeting inclusion criteria. We synthesized evidence across four policy analysis levels: efficacy, effectiveness, equity, and social justice. Data collection occurred January through December 2024.
resultsEvidence demonstrated safety and quality outcomes comparable to physician prescribing, with population-level prescribing decreases and no increase in overdose mortality. Nurse practitioners concentrated in rural areas at 34% compared to the 23% national average, with growth occurring during physician workforce decline. Patient panels showed 44% Medicaid coverage compared to 31% for physicians, with 88% versus 71% new Medicaid patient acceptance despite lower reimbursement. However, racial prescribing disparities persisted across all provider types, indicating systemic rather than individual-level determinants.
conclusionExpanded prescriptive authority advanced multiple policy objectives while revealing distinctive nursing contributions beyond physician substitution. Workforce distribution and patient panel patterns reflected professional values translating into measurable practice serving vulnerable populations. IMPACT: Evidence does not support restrictive policies based on safety concerns. Findings position the nursing workforce as an essential solution for health equity goals, requiring regulatory reform combined with institutional barrier removal and continuing attention to systemic inequities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.